Qualigen Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -754 | -364 | -4 | |
EBITDA | -1,387 | -1,214 | -1,894 | -2,232 |
EBIT | -1,268 | -1,215 | -1,895 | -2,236 |
Net Income | -1,794 | -1,576 | -2,032 | -2,467 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,799 | -1,474 | -783 | -5,671 |
Cash | 388 | 118 | 543 | 401 |
Basic Shares | 387 | 7,603 | 5,943 | 5,225 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,204 | $4,983 | $5,653 | $4,306 |
Gross Profit | -4 | 680 | 1,321 | -2,879 |
EBITDA | -11,300 | -13,841 | -22,663 | -11,164 |
EBIT | -11,304 | -13,853 | -22,985 | -11,303 |
Net Income | -13,417 | -21,034 | -17,897 | -20,418 |
Net Change In Cash | 5,204 | 4,983 | 5,653 | 4,306 |
Free Cash Flow | -10,304 | -13,566 | -14,872 | -9,965 |
Cash | 401 | 7,034 | 17,538 | 23,976 |
Basic Shares | 5,072 | 3,840 | 2,933 | 723 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$4.69 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.47 |
2023-12-31 | -$7.71 |
